Low density lipoprotein future or investigational therapies

Low Density Lipoprotein Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Physiology
Pathophysiology
Causes Low LDL High LDL
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Prognosis and Complications
Diagnosis
Laboratory Findings
Treatment
Medical Therapy
Landmark Trials
Future or Investigational Therapies
Case Studies
Case #1
Low density lipoprotein future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Low density lipoprotein future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Low density lipoprotein future or investigational therapies
CDC on Low density lipoprotein future or investigational therapies
Low density lipoprotein future or investigational therapies in the news
Blogs on Low density lipoprotein future or investigational therapies
Directions to Hospitals Treating Low density lipoprotein
Risk calculators and risk factors for Low density lipoprotein future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Table

Class	Drug Company	Agent Name	Mechanism of Action	Efficacy on Lowering LDL-C	Route of Administration	Adverse Effects	Published Clinical Trials
Inhibition of Apo B
PCSK9 Inhibition
MTP Inhibition
Thyromimetics
Squalene Synthase Inhibitors

References

Template:WikiDoc Sources